Mean or % (± SD and/or range) | |||
---|---|---|---|
Intervention group (n = 59) | Control group (n = 64) | ||
Age (years, mean) (range) | 83.2 ± 9.5 (59.8 – 102.7) | 86.6 ± 8.3 (70.1 – 105.4) | |
Female (%) | 72.9 | 81.3 | |
Follow-up (days, mean) | 165.9 | 188.4 | |
isoSMAF score (%) | 10 | 3.39 | 1.56 |
11 | 1.69 | 3.13 | |
12 | 11.86 | 10.94 | |
13 | 33.90 | 39.06 | |
14 | 49.15 | 45.31 | |
Charlson Comorbidity Score (mean) (range) | 6.88 ± 1.69 (3 – 10) | 7.31 ± 1.83 (4 – 14) | |
CMAI (mean) (range) | 39.1 ± 9.6 (30 – 80) | 36.0 ± 8.1 (30 – 62) | |
PACSLAC-F short version (mean) (range) | 4.93 ± 3.15 (1 – 17) | 4.05 ± 3.01 (1 – 15) | |
Died during follow-up (n (%)) | 17 (29%) | 20 (31%) |